Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Karuna Therapeutics, Inc. (KRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2023 4 Brown Jason Parker (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Granted 4,496 shares @ $0
Granted 7,696 options to buy @ $169.09, valued at $1.3M
10/03/2023 3 Brown Jason Parker (CFO) has filed a Form 3 on Karuna Therapeutics, Inc.
08/24/2023 4 Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 80 shares @ $173.64, valued at $13.9k
Sold 855 shares @ $174.88, valued at $149.5k
Sold 505 shares @ $175.59, valued at $88.7k
Sold 60 shares @ $176.6, valued at $10.6k
Exercised 1,500 options to buy @ $9.2, valued at $13.8k
08/10/2023 4 Brannan Stephen K. (Chief Medical Officer) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 2,395 shares @ $179.53, valued at $430k
Sold 1,355 shares @ $180.93, valued at $245.2k
Sold 1,250 shares @ $181.5, valued at $226.9k
Exercised 2,500 options to buy @ $5.45, valued at $13.6k
Exercised 5,000 options to buy @ $131.64, valued at $658.2k
08/02/2023 4 JONAS JEFFREY M (Director) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 3,399 shares @ $194.78, valued at $662.1k
Sold 6,301 shares @ $195.61, valued at $1.2M
Sold 3,110 shares @ $196.59, valued at $611.4k
Sold 400 shares @ $197.66, valued at $79.1k
Sold 600 shares @ $198.41, valued at $119k
Exercised 13,810 options to buy @ $7.27, valued at $100.4k
07/05/2023 4 OLSON LAURIE J (Director) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 600 shares @ $215.4, valued at $129.2k
Sold 400 shares @ $216.03, valued at $86.4k
Exercised 1,000 options to buy @ $84.86, valued at $84.9k
07/05/2023 4 JONAS JEFFREY M (Director) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 234 shares @ $214.61, valued at $50.2k
Sold 7,966 shares @ $215.91, valued at $1.7M
Sold 3,201 shares @ $216.78, valued at $693.9k
Sold 2,409 shares @ $217.82, valued at $524.7k
Exercised 13,810 options to buy @ $7.27, valued at $100.4k
05/25/2023 4 Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 724 shares @ $221.28, valued at $160.2k
Sold 2,093 shares @ $222.24, valued at $465.1k
Sold 3,309 shares @ $223.21, valued at $738.6k
Sold 1,070 shares @ $224.19, valued at $239.9k
Sold 1,022 shares @ $225.19, valued at $230.1k
Sold 782 shares @ $225.93, valued at $176.7k
Exercised 9,000 options to buy @ $9.2, valued at $82.8k
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 OLSON LAURIE J (Director) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 1,000 shares @ $181.02, valued at $181k
Exercised 1,000 options to buy @ $84.86, valued at $84.9k
03/09/2023 4 Brannan Stephen K. (Chief Medical Officer) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 5,000 shares @ $189.51, valued at $947.6k
Exercised 5,000 options to buy @ $5.45, valued at $27.3k
02/23/2023 4 Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 6,000 shares @ $190.01, valued at $1.1M
Exercised 6,000 options to buy @ $9.2, valued at $55.2k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2023 4 Kane William P Jr (Chief Commercial Officer) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Granted 17,656 shares @ $0
Granted 29,937 options to buy @ $192.15, valued at $5.8M
02/07/2023 3 Kane William P Jr (Chief Commercial Officer) has filed a Form 3 on Karuna Therapeutics, Inc.
01/19/2023 4 Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 817 shares @ $201.41, valued at $164.6k
Sold 200 shares @ $200.14, valued at $40k
Exercised 817 options to buy @ $9.2, valued at $7.5k
Exercised 200 options to buy @ $9.2, valued at $1.8k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Brannan Stephen K. (Chief Medical Officer) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 1,527 shares @ $197.52, valued at $301.6k
Sold 3,473 shares @ $197.52, valued at $686k
Exercised 1,527 options to buy @ $5.45, valued at $8.3k
Exercised 3,473 options to buy @ $7.27, valued at $25.2k
01/05/2023 4 COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Granted 321 options to buy @ $193.19, valued at $62k
Granted 407 options to buy @ $193.19, valued at $78.6k
Granted 67 options to buy @ $193.19, valued at $12.9k
Granted 181 options to buy @ $193.19, valued at $35k
01/05/2023 4 OLSON LAURIE J (Director) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Sold 1,000 shares @ $197.48, valued at $197.5k
Exercised 1,000 options to buy @ $84.86, valued at $84.9k
01/05/2023 4 Meury William (President and CEO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Granted 38,073 shares @ $0
Granted 63,065 options to buy @ $193.19, valued at $12.2M
01/05/2023 3 Meury William (President and CEO) has filed a Form 3 on Karuna Therapeutics, Inc.
12/22/2022 4 Miller Andrew Craig (COO) has filed a Form 4 on Karuna Therapeutics, Inc.
Txns: Exercised 7,100 options to buy @ $2.92, valued at $20.7k
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy